Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy.

Reif A, Richter J, Straube B, Höfler M, Lueken U, Gloster AT, Weber H, Domschke K, Fehm L, Ströhle A, Jansen A, Gerlach A, Pyka M, Reinhardt I, Konrad C, Wittmann A, Pfleiderer B, Alpers GW, Pauli P, Lang T, Arolt V, Wittchen HU, Hamm A, Kircher T, Deckert J.

Mol Psychiatry. 2014 Jan;19(1):122-8. doi: 10.1038/mp.2012.172. Epub 2013 Jan 15.

PMID:
23319006
2.

Therapygenetics: anterior cingulate cortex-amygdala coupling is associated with 5-HTTLPR and treatment response in panic disorder with agoraphobia.

Lueken U, Straube B, Wittchen HU, Konrad C, Ströhle A, Wittmann A, Pfleiderer B, Arolt V, Kircher T, Deckert J, Reif A.

J Neural Transm (Vienna). 2015 Jan;122(1):135-44. doi: 10.1007/s00702-014-1311-2. Epub 2014 Sep 16.

PMID:
25223844
3.

Facing the fear--clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia.

Liebscher C, Wittmann A, Gechter J, Schlagenhauf F, Lueken U, Plag J, Straube B, Pfleiderer B, Fehm L, Gerlach AL, Kircher T, Fydrich T, Deckert J, Wittchen HU, Heinz A, Arolt V, Ströhle A.

Eur Neuropsychopharmacol. 2016 Mar;26(3):431-44. doi: 10.1016/j.euroneuro.2016.01.004. Epub 2016 Jan 22.

PMID:
26837851
4.

Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder.

Kircher T, Arolt V, Jansen A, Pyka M, Reinhardt I, Kellermann T, Konrad C, Lueken U, Gloster AT, Gerlach AL, Ströhle A, Wittmann A, Pfleiderer B, Wittchen HU, Straube B.

Biol Psychiatry. 2013 Jan 1;73(1):93-101. doi: 10.1016/j.biopsych.2012.07.026. Epub 2012 Aug 24.

PMID:
22921454
5.

Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations.

Reif A, Weber H, Domschke K, Klauke B, Baumann C, Jacob CP, Ströhle A, Gerlach AL, Alpers GW, Pauli P, Hamm A, Kircher T, Arolt V, Wittchen HU, Binder EB, Erhardt A, Deckert J.

Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):786-93. doi: 10.1002/ajmg.b.32085. Epub 2012 Aug 22.

PMID:
22911667
6.

The functional -1019C/G HTR1A polymorphism and mechanisms of fear.

Straube B, Reif A, Richter J, Lueken U, Weber H, Arolt V, Jansen A, Zwanzger P, Domschke K, Pauli P, Konrad C, Gerlach AL, Lang T, Fydrich T, Alpers GW, Ströhle A, Wittmann A, Pfleiderer B, Wittchen HU, Hamm A, Deckert J, Kircher T.

Transl Psychiatry. 2014 Dec 16;4:e490. doi: 10.1038/tp.2014.130.

7.

MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy.

Ziegler C, Richter J, Mahr M, Gajewska A, Schiele MA, Gehrmann A, Schmidt B, Lesch KP, Lang T, Helbig-Lang S, Pauli P, Kircher T, Reif A, Rief W, Vossbeck-Elsebusch AN, Arolt V, Wittchen HU, Hamm AO, Deckert J, Domschke K.

Transl Psychiatry. 2016 Apr 5;6:e773. doi: 10.1038/tp.2016.41.

8.

Predicting treatment response to cognitive behavioral therapy in panic disorder with agoraphobia by integrating local neural information.

Hahn T, Kircher T, Straube B, Wittchen HU, Konrad C, Ströhle A, Wittmann A, Pfleiderer B, Reif A, Arolt V, Lueken U.

JAMA Psychiatry. 2015 Jan;72(1):68-74. doi: 10.1001/jamapsychiatry.2014.1741.

PMID:
25409415
9.

Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia.

Lueken U, Straube B, Konrad C, Wittchen HU, Ströhle A, Wittmann A, Pfleiderer B, Uhlmann C, Arolt V, Jansen A, Kircher T.

Am J Psychiatry. 2013 Nov;170(11):1345-55. doi: 10.1176/appi.ajp.2013.12111484.

PMID:
23982225
10.

Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.

Gloster AT, Wittchen HU, Einsle F, Lang T, Helbig-Lang S, Fydrich T, Fehm L, Hamm AO, Richter J, Alpers GW, Gerlach AL, Ströhle A, Kircher T, Deckert J, Zwanzger P, Höfler M, Arolt V.

J Consult Clin Psychol. 2011 Jun;79(3):406-20. doi: 10.1037/a0023584. Erratum in: J Consult Clin Psychol. 2011 Oct; 79(5):652. Alpers, George W [corrected to Alpers, Georg W].

PMID:
21534651
11.

Neural correlates of procedural variants in cognitive-behavioral therapy: a randomized, controlled multicenter FMRI study.

Straube B, Lueken U, Jansen A, Konrad C, Gloster AT, Gerlach AL, Ströhle A, Wittmann A, Pfleiderer B, Gauggel S, Wittchen U, Arolt V, Kircher T.

Psychother Psychosom. 2014;83(4):222-33. doi: 10.1159/000359955. Epub 2014 Jun 19.

PMID:
24970601
12.

Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan.

Wang TJ, Huang SY, Lin WW, Lo HY, Wu PL, Wang YS, Wu YS, Ko HC, Shih JC, Lu RB.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):108-14. Epub 2006 Sep 27.

PMID:
17007976
13.

Separating depressive comorbidity from panic disorder: A combined functional magnetic resonance imaging and machine learning approach.

Lueken U, Straube B, Yang Y, Hahn T, Beesdo-Baum K, Wittchen HU, Konrad C, Ströhle A, Wittmann A, Gerlach AL, Pfleiderer B, Arolt V, Kircher T.

J Affect Disord. 2015 Sep 15;184:182-92. doi: 10.1016/j.jad.2015.05.052. Epub 2015 Jun 6.

PMID:
26093832
14.

Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G.

Cochrane Database Syst Rev. 2016 Apr 13;4:CD011004. doi: 10.1002/14651858.CD011004.pub2. Review.

15.

5HTT is associated with the phenotype psychological flexibility: results from a randomized clinical trial.

Gloster AT, Gerlach AL, Hamm A, Höfler M, Alpers GW, Kircher T, Ströhle A, Lang T, Wittchen HU, Deckert J, Reif A.

Eur Arch Psychiatry Clin Neurosci. 2015 Aug;265(5):399-406. doi: 10.1007/s00406-015-0575-3. Epub 2015 Jan 15.

PMID:
25588519
16.

Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder?

Domschke K, Tidow N, Kuithan H, Schwarte K, Klauke B, Ambrée O, Reif A, Schmidt H, Arolt V, Kersting A, Zwanzger P, Deckert J.

Int J Neuropsychopharmacol. 2012 Oct;15(9):1217-28. doi: 10.1017/S146114571200020X. Epub 2012 Mar 21.

PMID:
22436428
17.

A new paradigm (Westphal-Paradigm) to study the neural correlates of panic disorder with agoraphobia.

Wittmann A, Schlagenhauf F, John T, Guhn A, Rehbein H, Siegmund A, Stoy M, Held D, Schulz I, Fehm L, Fydrich T, Heinz A, Bruhn H, Ströhle A.

Eur Arch Psychiatry Clin Neurosci. 2011 Apr;261(3):185-94. doi: 10.1007/s00406-010-0167-1. Epub 2010 Nov 27.

PMID:
21113608
18.

Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.

Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nöthen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP.

Hum Mol Genet. 1999 Apr;8(4):621-4.

PMID:
10072430
19.

[The research network PANIC-NET: improving the treatment of panic disorder - from a better understanding of fear circuit mechanisms to more effective psychological treatment and routine care].

Arolt V, Zwanzger P, Ströhle A, Hamm A, Gerlach A, Kircher T, Deckert J.

Psychother Psychosom Med Psychol. 2009 Mar-Apr;59(3-4):124-31. doi: 10.1055/s-0029-1202781. Epub 2009 Apr 6. Review. German. Erratum in: Psychother Psychosom Med Psychol. 2009 Sep-Oct;59(9-10):344. Zwanziger, Peter [corrected to Zwanzger, Peter].

PMID:
19350472
20.

Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobia.

Lueken U, Straube B, Reinhardt I, Maslowski NI, Wittchen HU, Ströhle A, Wittmann A, Pfleiderer B, Konrad C, Ewert A, Uhlmann C, Arolt V, Jansen A, Kircher T.

Psychol Med. 2014 Jan;44(2):381-94. doi: 10.1017/S0033291713000792. Epub 2013 Apr 23.

PMID:
23611156

Supplemental Content

Support Center